Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
NCT ID: NCT03949049
Last Updated: 2019-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
40 participants
INTERVENTIONAL
2019-02-01
2029-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Early Use of Caffeine Citrate in Preterm Neonates
NCT04001712
Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate
NCT04110418
Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term Newborns
NCT04358822
Codeine in Mechanically Ventilated Neonates
NCT01322204
Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome
NCT04283578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Citacoline
Citacoline as neuroprotector
Citicoline
Citacoline as neuroprotector
Placebo
Placebo
Placebo
placebo group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Citicoline
Citacoline as neuroprotector
Placebo
placebo group
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Month
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Ass Prof Tanta University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abeer Salamah, Lecturer
Role: PRINCIPAL_INVESTIGATOR
Pediatrics department - Kafr-Elsheikh university
May R Elsheikh, Lecturer
Role: STUDY_CHAIR
Pediatrics department - Tanta university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sherief Abd-Elsalam
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Salamah A, El Amrousy D, Elsheikh M, Mehrez M. Citicoline in hypoxic ischemic encephalopathy in neonates: a randomized controlled trial. Ital J Pediatr. 2023 May 12;49(1):55. doi: 10.1186/s13052-023-01452-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
neonates tanta
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.